Products - Heart failure | Topic | NICE

Showing 13 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
Status: PublishedRemove ‘Status: Published’ filter

Pulmonary artery pressure technologies for remote monitoring of chronic heart failure (HTG769)
Product type:
Guidance
Programme:
HealthTech guidance
Published:
5 February 2026
Chronic heart failure in adults: diagnosis and management (NG106)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
3 September 2025
Published:
12 September 2018
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (HTG730)
Product type:
Guidance
Programme:
HealthTech guidance
Published:
24 October 2024
Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (TA929)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
1 November 2023
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (TA902)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
21 June 2023
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal) (TA790)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
25 May 2022
Empagliflozin for treating chronic heart failure with reduced ejection fraction (TA773)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
9 March 2022
Acute heart failure: diagnosis and management (CG187)
Product type:
Guidance
Programme:
Clinical guideline
Last updated:
17 November 2021
Published:
8 October 2014
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal) (TA731)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
29 September 2021
Dapagliflozin for treating chronic heart failure with reduced ejection fraction (TA679)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
24 February 2021
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction (TA388)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 April 2016
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (TA314)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
25 June 2014
Ivabradine for treating chronic heart failure (TA267)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
28 November 2012